Skip to main content
BioThera Solutions

Freeze-dried extracellular vesicles (exosomes): does lyophilization damage them, and how should they be stored?

Extracellular vesicles can still be present in a vial long after they have stopped doing anything. Storage, not isolation, is where many EV products quietly lose their activity. Freeze-drying can fix that, if it is done and checked properly.

FS

Frédéric St-Denis-Bissonnette, PhD

Founder & CEO, BioThera Solutions

Extracellular vesicles (EVs, often marketed as exosomes) are biological material. A vial can still contain the expected number of particles and the expected proteins after its biological activity is gone. For a buyer, that makes storage one of the most important and least discussed parts of an EV product.

Why liquid EV products lose activity

In a liquid preparation, three things work against the vesicles at once. Proteins on and inside them slowly unfold and lose function. Vesicles collide and clump. And any microbes present have water to grow in. Heat speeds all three up.

The difficulty is that these losses are mostly invisible to a particle count. Nanoparticle Tracking Analysis can still report a healthy concentration while the proteins that made the preparation useful have degraded. A liquid serum or cream kept at room temperature for months is therefore a different product from the one that left the production line, even if its label still shows the same number.

So the storage question to ask a supplier is not only "what temperature?" but "what format, and what evidence shows it is stable in that format?"

How freeze-drying works

Lyophilization, or freeze-drying, removes nearly all of the water from a preparation. It runs in three steps:

  1. Freeze. The preparation is frozen solid, locking its water into ice.
  2. Remove the ice. Under deep vacuum, the ice turns straight into vapour without melting and is drawn away.
  3. Seal it dry. What remains is a dry material, sealed against moisture until it is reconstituted.

Without water, the processes that degrade a biological product slow dramatically. That is why lyophilization is used for many vaccines and injectable medicines, and why a well-made lyophilized EV product can be stored and shipped at room temperature.

How freeze-drying can go wrong

Lyophilization is technically demanding. Ice crystals can puncture membranes. Vesicles can fuse or aggregate as they are concentrated during freezing. Too much residual water undoes the stability benefit. A protective excipient, usually a sugar such as trehalose, is normally needed to hold the vesicle structure in place as the water leaves.

None of this shows on the label. A lyophilized powder looks the same whether the vesicles inside survived intact or not.

How to check whether lyophilization damaged the vesicles

The test is a before-and-after comparison on the same batch: characterize the preparation before freeze-drying, reconstitute it, and characterize it again. Useful measurements include:

  • Transmission electron microscopy (TEM) to look at vesicle morphology directly: intact, round, membrane-bounded particles versus ruptured or fused ones.
  • Nanoparticle Tracking Analysis (NTA) to compare particle concentration and size distribution. A shift to larger sizes suggests aggregation; a large drop in particles suggests loss.
  • Protein and purity measures, such as particle-to-protein ratio, to see whether the composition changed.

A supplier selling a lyophilized EV product should be able to tell you whether it has run this comparison and what it found.

What BioThera has observed

BioThera's current plant-derived EV material is lyophilized and stored at room temperature, with a shelf life of 5 years from manufacture. In our internal analyses, comparing material before lyophilization with the same material after reconstitution, including by TEM with the positive staining protocol our founder published in Langmuir, we have not observed changes in vesicle morphology or the other characteristics we measured.

These are BioThera's own results on its own material. They do not transfer to another product made with a different isolation method or a different freeze-drying protocol, which is exactly why the question has to be asked of each supplier.

Storage after reconstitution

Once water is added back, the clock starts again. For BioThera's material, each vial is reconstituted with the provided diluent, and the reconstituted material keeps:

  • at 4 °C (refrigerated) for up to 1 month, or
  • frozen for up to 1 year.

Reconstituted material should not be left at room temperature, and repeated freezing and thawing should be avoided. Stability work on reconstituted material in day-to-day use is ongoing, and these figures will be updated if the data change.

Questions to ask about any EV product's storage

  • Is the product supplied as a liquid, frozen, or lyophilized?
  • What storage temperature is specified, and what shelf life, backed by what stability data?
  • If lyophilized, was the material characterized before and after freeze-drying, and by which methods?
  • How long does it keep after reconstitution or opening, and at what temperature?
  • How is temperature controlled during shipping for formats that need it?

The implication

A particle count tells you what is in the vial. Storage data tells you whether it still works. For EV products, the second answer is the one most labels leave out, and the one a careful buyer should insist on.

For the broader evaluation framework, see how to evaluate an EV or exosome product. The Technology page explains how BioThera's process is built.

Want more EV science in your Google results?

Add BioThera Solutions as a preferred source on Google

Primary sources

  1. Welsh JA, et al. (incl. St-Denis-Bissonnette F). Minimal information for studies of extracellular vesicles (MISEV2023). Journal of Extracellular Vesicles, 2024. doi.org/10.1002/jev2.12404
  2. St-Denis-Bissonnette F, et al.. An optimized positive staining protocol for clear visualization of extracellular vesicles by TEM using uranyless and lead citrate. Langmuir, 2026. doi.org/10.1021/acs.langmuir.5c03977

Questions on this topic?

Clinicians, researchers, and partners are welcome to go deeper. We treat scientific dialogue as a working part of the platform, not a sales channel.

BioThera Solutions

A fully integrated extracellular vesicle company, from research and intellectual property to manufacturing, with a process designed to scale. Extracellular vesicles (EVs/exosomes) are among biology's most promising delivery systems, and we are building the infrastructure the field has been missing.

Ottawa, Ontario, Canada
477-150 Louis-Pasteur Private Ottawa, Ontario K1N 9B4 Canada
Add BioThera Solutions as a preferred source on Google

© 2026 BioThera Solutions Inc. All rights reserved.

For informational purposes only. Nothing on this website is medical advice. BioThera develops and manufactures characterized extracellular vesicles (exosomes) and, for cosmetic applications, licenses its technology exclusively to Vesera™, a skincare company and BioThera subsidiary. Vesera™ products are cosmetics and are not intended to diagnose, treat, cure, or prevent any disease. BioThera does not sell products to consumers, and its work on therapeutic applications is research only.